QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aest... ( LES ULIS France September 3 /- .....)

QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH

Date:9/3/2007

LES ULIS, France, September 3 /PRNewswire-FirstCall/ --

- QUANTEL has Entered Into the Final Phase of the Negotiations in View of Acquiring the Company WaveLight Aesthetic GmbH

A strong complementarity

This company, a subsidiary of the German company WaveLight AG, is specialized in Dermatology/Aesthetic lasers. It is based in Germany, in Erlangen, near Nuremberg and its revenues are estimated of approx. 10MEUR for the fiscal year 2006/2007 ended July 31, 2007.

Its product line is very complementary with Quantel Medical's with, in particular, lasers for tattoo removal, hair removal and skin resurfacing.

A powerful and profitable Dermatology division

The combination of Quantel Medical's Dermatology's activities with those of WaveLight Aesthetic will create a Dermatology division with a very complete product offering and which could make more than 20MEUR in sales in 2008. This would lead to good profitability in a very large and fast growing market.

Achieving the objectives set by WaveLight Aesthetic's management, who will remain in place, should be immediately accretive to the Group's profits.

Both parties intend to sign final agreements before the end of September 2007.

The terms and conditions of the financing for this acquisition are still being negotiated. They will be published soon.

ABOUT THE QUANTEL GROUP

Founded in 1970, the QUANTEL Group has over the last 10 years established itself as one of the world's leading specialists for scientific (research laboratories, universities), industrial (micromachining, metrics, military) and medical (ophthalmology, dermatology) laser technologies.

Located in France and the US, through its Big Sky Laser subsidiary, the QUANTEL Group generated EUR2.1 million in net income in 2006 and EUR41.4 million in revenues, with 81% on international markets, split between scientific and industrial applications (51%) and medical clients (49%) for lasers.

'/>"/>

SOURCE QUANTEL
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Creatine Helps Strengthen Older Men
2. Marijuana gateway theory strengthened by study of twins
3. New Compound Could Strengthen The Effect Of Chemotherapy
4. More collaborations and strengthening of India’s AIDS control body require
5. Magnesium In Diet Strengthens Bones
6. Soft Drinks Can Strengthen Memory Power
7. Internet Helps Strengthen Social Ties
8. Strengthen Your Childs Immunity Give Him A Cat
9. Communication in the ICU to Be Strengthened
10. MSU Research Strengthens Link Between Smoking, Pancreatic Cancer
11. U.N. Officials Call on Countries To Strengthen HIV/AIDS Prevention Efforts

Post Your Comments:

(Date:11/9/2009)...re-USNewswire/ -- For the third consecutive year, ...lected the most preferred hospital for cancer care...he National Research Corporation. ,, (Logo: ...NOSLOGO ) ,, The annual survey was conducted t...08 and August 2009. Survey respondents were the pr...

(Date:11/9/2009)...ire/ -- Phoenix House , the nation,s leading ...evention program, announced today its appointment ...nally recognized leader in substance abuse treatme...ive January 1, 2010. ,, "Dr. Deni Carise is a...research and her work has resulted in a significan...

(Date:11/9/2009)... At a time when the 250,000+ eligi...concerned about finding affordable health insuranc... 2010. ,, The Today,s Options® Preferred P... provides a cost-effective and comprehensive alter...nt plan. People with Medicare can choose to sign ...

(Date:11/9/2009)...wire/ -- , , WHAT: All PETCO stores nationw...orkshop facilitated by specially trained in-store ...ber 14 at 2 p.m. During the 30-minute, ...itional needs of, their dogs and cats... good pet nutrition, receive an assessment o...

(Date:11/9/2009)...cember issue of European Urology , the official j...tures an article entitled ,Are Infertile Men Less ... Case-Control Survey, by Dr. Andrea Salonia et al.... associated with a number of medical comorbidities...arlson Comorbidity Index. , Dr. Andrea Salonia f...

Breaking Medicine News(10 mins):Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2 Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2 Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3 Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2 Health News:European Urology: Male factor infertility associated with comorbidities 2

[0] Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year [0] Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research [0] Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option [0] PETCO Stores Nationwide Host Pet Nutrition Workshops [0] European Urology: Male factor infertility associated with comorbidities

...ction to be Favored, ADDIS ABABA, Ethiopia, Jan. ...eric drug manufacturing subsidiary of,Rx for Afric...fit greatly,from powerful new incentives for Ethio...port of our,burgeoning industry. The health of Eth...

...nues Benefit from Strong International Performance...Sales, GLENWOOD, Ill., Jan. 31 Landauer, Inc. (N...ironmental radiation,monitoring, today reported re...ion on higher international revenues in severa...

...) survey reveals Boomers feel young, but often ign...fitness expert Denise Austin to launch .... 31 Baby boomers are living,longer and leading m...Holdings, Inc. (NYSE: ENR ), nearly two-thirds,(6...

... Jan. 31, 2008 The Procter &,Gamble Company (NYSE... to,$21.6 billion for the quarter. Sales were up b...on key product initiatives and double-digit organi...e increased 17 percent to $0.98 per share, above t...

...easoned Employees through Long Term Healthcare Edu...mes, older,experienced employees are the ones comp...leave of their own accord. Or they may start takin...Director of Business Development for LTC Financial...

...ith rheumatoid arthritis (RA), an inflammatory aut...from cardiovascular disease (CVD). One explanatio...flammation promotes atherosclerosis. A marker of ...tory diseasesCrohns, for exampledo not carry the s...

Rx for Africa, Inc. to Benefit from New Ethiopian Government Policy on Pharma Industry Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results Boomers: Feeling Young or Fooling Themselves?P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company Protecting Productivity at the Worksite in Challenging Times The HLA-DRB1 gene and premature death in rheumatoid arthritis

(Date:11/9/2009)... PAREXEL International Corporation (Nasdaq: PRXL ...vider, today announced that it has enhanced its ca... development through an alliance with Mortara Inst...lectrocardiogram (ECG) devices and related technol...,s Surveyor Telemetry Central System to supplement...

(Date:11/8/2009)...re Reform Bill ,, Critical legislation would ...icans ,, BOISE, Idaho, Nov. 7 /PRNewswire-US...esentatives passed critical health care reform leg...s and end discrimination by insurance companies th...health coverage. ,, The Affordable Health Car...

(Date:11/6/2009)...Call/ -- SCOLR Pharma, Inc. (Amex: DDD ) today re...nths ended September 30, 2009. ,, Stephen J. ...e continue to advance discussions related to licen...tential partners have committed significant resour...hey evaluate the potential commercial and/or licen...

Breaking Medicine Technology:PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5 AARP Idaho Key Vote News Alert 2 AARP Idaho Key Vote News Alert 3 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9 Printing New Organs 3A Foundation Funds Medical Technology That Replicates Human Tissue 12545 1 Printing New Organs 3A Foundation Funds Medical Technology That Replicates Human Tissue 12545 2 NIAHC Premiers Its Natural Health Care and Balanced Living Website 48305 1 NIAHC Premiers Its Natural Health Care and Balanced Living Website 48305 2 Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 1 Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 2 Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 3

[0] PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument [0] AARP Idaho Key Vote News Alert [0] SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

...ng,published in this Friday,s online edition of Ce...inson,s disease?, One of the most pressing questi...se is what causes the sensitive cells in the brain...n has been especially difficult,because there are ...duce,dopamine and they are mixed together in the s...

... Reversible, High-level Platelet Inhi...ANS and SOUTH SAN FRANCISCO, Calif., Nov. 12 ,Port...eveloping innovative,drugs that provide significan...ases, and cancer, today announced new clinical dat...anti-platelet drug that directly and,reversibly in...

Other Medicine Technology:A Window Into Parkinson's Disease 2 Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 2 Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 3

A Window Into Parkinson's Disease Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders

...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...

Medicine Products:

C3 Proactivator C3 C-1-Esterase Inhibitor Panel C12

QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aest...( LES ULIS France September 3 /- .....),Health